US Stock MarketDetailed Quotes

COCH Envoy Medical

Watchlist
  • 3.100
  • -0.010-0.32%
Close Sep 6 16:00 ET
60.76MMarket Cap-2031P/E (TTM)

Envoy Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.67%-4.91M
-94.15%-5.85M
-100.50%-17.65M
-392.14%-11.71M
144.35%1.1M
-4.03M
-3.01M
-26.95%-8.81M
-2.38M
-2.48M
Net income from continuing operations
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
209.93%1.47M
---13.25M
---13.25M
-83.55%-15.92M
---11.48M
---1.34M
Operating gains losses
---1.05M
1,184.62%1.34M
-5,362.86%-1.84M
-14,391.67%-1.72M
---231K
--0
--104K
3,400.00%35K
--12K
----
Depreciation and amortization
44.83%42K
25.93%34K
77.33%133K
84.62%48K
31.82%29K
--29K
--27K
5.63%75K
--26K
--22K
Other non cash items
-107.69%-676K
-99.67%31K
86.50%13.45M
-99.65%30K
-778.68%-4.78M
--8.8M
--9.4M
312.41%7.21M
--8.6M
---544K
Change In working capital
3.33%403K
-263.77%-1.19M
-498.75%-958K
-1,485.31%-6.79M
836.56%4.71M
--390K
--726K
-95.12%-160K
--490K
---640K
-Change in receivables
195.00%19K
316.67%25K
-536.17%-205K
-344.64%-137K
---54K
---20K
--6K
347.37%47K
--56K
--0
-Change in inventory
-5,100.00%-300K
---140K
94.85%-10K
-193.75%-30K
109.33%14K
--6K
--0
-452.73%-194K
--32K
---150K
-Change in prepaid assets
159.38%76K
-16.22%-43K
-2,278.95%-828K
-46.67%40K
-511.30%-703K
---128K
---37K
265.22%38K
--75K
---115K
-Change in payables and accrued expense
-120.97%-138K
-219.09%-998K
-3.79%457K
-906.71%-6.62M
1,730.41%5.58M
--658K
--838K
541.89%475K
--820K
---342K
-Change in other current liabilities
692.06%746K
59.26%-33K
29.28%-372K
90.67%-46K
-260.61%-119K
---126K
---81K
-211.24%-526K
---493K
---33K
Cash from discontinued investing activities
Operating cash flow
-21.67%-4.91M
-94.15%-5.85M
-100.50%-17.65M
-392.14%-11.71M
144.35%1.1M
---4.03M
---3.01M
-26.95%-8.81M
---2.38M
---2.48M
Investing cash flow
Cash flow from continuing investing activities
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
-11K
-59K
-74.40%-218K
-41K
-76K
Net PPE purchase and sale
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
---11K
---59K
-74.40%-218K
---41K
---76K
Cash from discontinued investing activities
Investing cash flow
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
---11K
---59K
-74.40%-218K
---41K
---76K
Financing cash flow
Cash flow from continuing financing activities
-16.67%2.5M
67.08%6.68M
169.96%21.85M
-144.55%-891K
408.93%15.74M
3M
4M
0.42%8.09M
2M
3.09M
Net issuance payments of debt
-16.67%2.5M
25.00%5M
25.00%10M
--0
0.00%3M
--3M
--4M
0.00%8M
--2M
--3M
Net common stock issuance
--0
--1.68M
--109K
----
----
--0
--0
--0
----
----
Net preferred stock issuance
----
----
--11.74M
--0
----
----
----
--0
--0
----
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
58.62%92K
--0
----
Cash from discontinued financing activities
Financing cash flow
-16.67%2.5M
67.08%6.68M
169.96%21.85M
-144.55%-891K
408.93%15.74M
--3M
--4M
0.42%8.09M
--2M
--3.09M
Net cash flow
Beginning cash position
343.90%4.95M
2,204.92%4.22M
-83.68%183K
2,665.19%16.84M
-5.56%68K
--1.11M
--183K
736.57%1.12M
--609K
--72K
Current changes in cash
-206.03%-3.2M
-21.72%728K
533.73%4.04M
-2,904.76%-12.62M
3,017.66%16.77M
---1.05M
--930K
-193.38%-931K
---420K
--538K
Effect of exchange rate changes
0.00%-1K
-200.00%-1K
57.14%-3K
66.67%-2K
---1K
---1K
--1K
30.00%-7K
---6K
----
End cash Position
2,467.65%1.75M
343.90%4.95M
2,204.92%4.22M
2,204.92%4.22M
2,665.19%16.84M
--68K
--1.11M
-83.68%183K
--183K
--609K
Free cash flow
-40.87%-5.7M
-93.97%-5.96M
-97.35%-17.81M
-384.67%-11.73M
140.60%1.04M
---4.05M
---3.07M
-27.79%-9.02M
---2.42M
---2.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.67%-4.91M-94.15%-5.85M-100.50%-17.65M-392.14%-11.71M144.35%1.1M-4.03M-3.01M-26.95%-8.81M-2.38M-2.48M
Net income from continuing operations 70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M209.93%1.47M---13.25M---13.25M-83.55%-15.92M---11.48M---1.34M
Operating gains losses ---1.05M1,184.62%1.34M-5,362.86%-1.84M-14,391.67%-1.72M---231K--0--104K3,400.00%35K--12K----
Depreciation and amortization 44.83%42K25.93%34K77.33%133K84.62%48K31.82%29K--29K--27K5.63%75K--26K--22K
Other non cash items -107.69%-676K-99.67%31K86.50%13.45M-99.65%30K-778.68%-4.78M--8.8M--9.4M312.41%7.21M--8.6M---544K
Change In working capital 3.33%403K-263.77%-1.19M-498.75%-958K-1,485.31%-6.79M836.56%4.71M--390K--726K-95.12%-160K--490K---640K
-Change in receivables 195.00%19K316.67%25K-536.17%-205K-344.64%-137K---54K---20K--6K347.37%47K--56K--0
-Change in inventory -5,100.00%-300K---140K94.85%-10K-193.75%-30K109.33%14K--6K--0-452.73%-194K--32K---150K
-Change in prepaid assets 159.38%76K-16.22%-43K-2,278.95%-828K-46.67%40K-511.30%-703K---128K---37K265.22%38K--75K---115K
-Change in payables and accrued expense -120.97%-138K-219.09%-998K-3.79%457K-906.71%-6.62M1,730.41%5.58M--658K--838K541.89%475K--820K---342K
-Change in other current liabilities 692.06%746K59.26%-33K29.28%-372K90.67%-46K-260.61%-119K---126K---81K-211.24%-526K---493K---33K
Cash from discontinued investing activities
Operating cash flow -21.67%-4.91M-94.15%-5.85M-100.50%-17.65M-392.14%-11.71M144.35%1.1M---4.03M---3.01M-26.95%-8.81M---2.38M---2.48M
Investing cash flow
Cash flow from continuing investing activities -7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K-11K-59K-74.40%-218K-41K-76K
Net PPE purchase and sale -7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K---11K---59K-74.40%-218K---41K---76K
Cash from discontinued investing activities
Investing cash flow -7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K---11K---59K-74.40%-218K---41K---76K
Financing cash flow
Cash flow from continuing financing activities -16.67%2.5M67.08%6.68M169.96%21.85M-144.55%-891K408.93%15.74M3M4M0.42%8.09M2M3.09M
Net issuance payments of debt -16.67%2.5M25.00%5M25.00%10M--00.00%3M--3M--4M0.00%8M--2M--3M
Net common stock issuance --0--1.68M--109K----------0--0--0--------
Net preferred stock issuance ----------11.74M--0--------------0--0----
Proceeds from stock option exercised by employees ----------0--0------------58.62%92K--0----
Cash from discontinued financing activities
Financing cash flow -16.67%2.5M67.08%6.68M169.96%21.85M-144.55%-891K408.93%15.74M--3M--4M0.42%8.09M--2M--3.09M
Net cash flow
Beginning cash position 343.90%4.95M2,204.92%4.22M-83.68%183K2,665.19%16.84M-5.56%68K--1.11M--183K736.57%1.12M--609K--72K
Current changes in cash -206.03%-3.2M-21.72%728K533.73%4.04M-2,904.76%-12.62M3,017.66%16.77M---1.05M--930K-193.38%-931K---420K--538K
Effect of exchange rate changes 0.00%-1K-200.00%-1K57.14%-3K66.67%-2K---1K---1K--1K30.00%-7K---6K----
End cash Position 2,467.65%1.75M343.90%4.95M2,204.92%4.22M2,204.92%4.22M2,665.19%16.84M--68K--1.11M-83.68%183K--183K--609K
Free cash flow -40.87%-5.7M-93.97%-5.96M-97.35%-17.81M-384.67%-11.73M140.60%1.04M---4.05M---3.07M-27.79%-9.02M---2.42M---2.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg